sotorasib,carboplatin,pemetrexed 
amgen
['sclc', 'nsclc', 'sotorasib']
#scarlet data shows impressive 89% orr for sotorasib + chemo in 1l kras g12c-mut nsclc but relatively underwhelming ~6 month mpfs. delaying/preventing acquired resistance to g12ci remains a major challenge, data suggests partnering with chemo minimally effective. #asco23 
Medical oncology fellow @MSKcancercenter, prior @oslerresidency @harvardmed @yale. Precision medicine, thoracic cancers, Miami sports.